<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Resistance to cytotoxic agents is a common clinical problem encountered in the treatment of human <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:hpo ids='HP_0011009'>acute</z:hpo> myeloblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Cellular acquisition of the multidrug resistance (<z:chebi fb="14" ids="53218">MDR</z:chebi>) phenotype confers loss of sensitivity to a wide range of structurally dissimilar anti-neoplastic agents </plain></SENT>
<SENT sid="2" pm="."><plain>This state can arise through increased expression of the mdrl (P-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi>) gene </plain></SENT>
<SENT sid="3" pm="."><plain>We have used the mdrl gene probe to investigate adriamycin resistant (HL60/AR) and vinblastine resistant (CEM/VLB100) human leukaemic cell lines </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, peripheral blood or bone marrow cells from 66 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> have been screened for gene amplification and 40 cases for increased <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression </plain></SENT>
<SENT sid="5" pm="."><plain>P-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> gene amplification was observed only in the (CEM/VLB100) and not in the HL60/AR on any other leukaemic cell line </plain></SENT>
<SENT sid="6" pm="."><plain>Gene amplification was not found in any patient's cells </plain></SENT>
<SENT sid="7" pm="."><plain>Eighteen out of 40 patients showed an increase (2----20) of mdrl <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression </plain></SENT>
<SENT sid="8" pm="."><plain>These results are not only of significance in understanding the biology of human drug resistance but have practical importance in the design of anti-leukaemic therapy </plain></SENT>
</text></document>